The Nervous System and Inflammation

Inflammation is the immune system's coordinated response to injury, infection, or perceived threat. It involves a cascade of cellular and molecular events—vascular changes, immune cell recruitment, cytokine release—that aim to contain damage and initiate repair. Acute inflammation is self-limiting and adaptive. Chronic inflammation, by contrast, persists beyond the resolution of the original insult, often without clear infectious or traumatic cause, and becomes a driver of pathology in its own right.

The nervous system does not observe inflammation passively. It participates in its initiation, modulation, and resolution through direct neural pathways, neuroendocrine signaling, and bidirectional communication with immune cells. The vagus nerve, for instance, can suppress cytokine production via the cholinergic anti-inflammatory pathway. The hypothalamic-pituitary-adrenal axis regulates glucocorticoid release in response to inflammatory signals. Sensory neurons detect immune mediators and alter pain thresholds, behavior, and autonomic tone. This is not metaphor. It is measurable physiology.

Chronic Inflammatory Response Syndrome (CIRS), a condition characterized by prolonged multi-system inflammation often triggered by biotoxin exposure, exemplifies what happens when these regulatory loops fail. Symptoms span cognition, mood, pain, and autonomic function—domains historically siloed into separate specialties but unified by a common substrate: a nervous system attempting to predict and respond to an environment it cannot resolve.

Chronic inflammation is implicated in nearly every major category of disease burden in high-income countries: cardiovascular disease, type 2 diabetes, neurodegenerative disorders, depression, autoimmune conditions, and cancer. Elevated circulating markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) predict morbidity and mortality across populations, independent of traditional risk factors. Yet inflammation is rarely the primary diagnosis. It appears instead as a feature, a comorbidity, a laboratory anomaly—something to note but not necessarily to treat.

This fragmentation reflects a deeper conceptual problem. Medicine has historically treated inflammation as either helpful (acute, appropriate) or harmful (chronic, aberrant), but not as a process actively shaped by the nervous system's predictions about safety, threat, and resource allocation. When the nervous system predicts ongoing danger—whether from unresolved infection, environmental toxins, psychosocial stress, or metabolic dysregulation—it maintains an inflammatory posture. This is not irrational. It is an attempt at coherence.

For clinicians, this reframing has practical consequences. A patient presenting with fatigue, brain fog, joint pain, and mood disturbance may receive separate referrals to rheumatology, psychiatry, and neurology. Each specialist may find something—elevated inflammatory markers, subclinical hypothyroidism, mild cognitive impairment—but no single explanation. The nervous system, however, is attempting to solve a unified problem: how to function in a body it perceives as under threat.

CIRS offers a particularly instructive case. Patients often describe years of diagnostic odyssey, dismissed as anxious or somatizing, before a clinician considers biotoxin exposure and measures inflammatory mediators, visual contrast sensitivity, or genetic susceptibility markers like HLA-DR/DQ haplotypes. The condition is controversial, not because the inflammation is absent, but because the causal narrative—mold, Lyme, water-damaged buildings—does not fit neatly into conventional diagnostic categories. What is not controversial is that these patients suffer, and that their suffering has a neuroimmune signature.

The bidirectional communication between the nervous system and immune system is now well-documented. The cholinergic anti-inflammatory pathway, first described by Tracey and colleagues in the early 2000s, demonstrates that vagal efferent signaling can inhibit macrophage production of tumor necrosis factor-alpha (TNF-α) and other pro-inflammatory cytokines via alpha-7 nicotinic acetylcholine receptors (Pavlov & Tracey, 2022). This pathway is not merely modulatory; it is essential for preventing runaway inflammation in sepsis and autoimmune disease. Vagus nerve stimulation, both invasive and transcutaneous, has shown efficacy in reducing inflammatory markers in rheumatoid arthritis and inflammatory bowel disease, with effects mediated through this cholinergic mechanism (Bonaz et al., 2021).

Conversely, peripheral inflammation signals the brain. Cytokines such as IL-1β, IL-6, and TNF-α can cross the blood-brain barrier at circumventricular organs, bind to receptors on cerebral endothelial cells, or activate vagal afferents that relay inflammatory status to the nucleus tractus solitarius and ultimately to cortical and limbic regions (Miller & Raison, 2023). This signaling induces sickness behavior—lethargy, anhedonia, social withdrawal, hyperalgesia—a coordinated suite of responses that prioritize immune defense over exploration and reproduction. In the acute setting, this is adaptive. In chronic low-grade inflammation, it becomes depression, chronic pain, and cognitive impairment.

Recent neuroimaging work has identified inflammation-related changes in brain structure and function. A 2023 study in *JAMA Psychiatry* found that individuals with major depressive disorder and elevated CRP showed reduced connectivity in the ventral striatum and increased activity in the dorsal anterior cingulate cortex, regions involved in reward processing and threat detection (Mehta et al., 2023). Another study in *Nature Medicine* demonstrated that peripheral IL-6 levels correlate with microglial activation measured via PET imaging in patients with treatment-resistant depression (Attwells et al., 2022). These findings suggest that inflammation does not merely accompany psychiatric symptoms; it reconfigures the neural circuits that generate them.

CIRS, as described by Shoemaker and colleagues, represents a chronic inflammatory state triggered by exposure to biotoxins—most commonly mycotoxins from water-damaged buildings, but also Lyme disease, ciguatera, and other sources. The proposed mechanism involves innate immune activation in genetically susceptible individuals (particularly those with HLA-DR/DQ haplotypes that impair biotoxin clearance), leading to persistent elevation of cytokines, complement activation, transforming growth factor-beta 1 (TGF-β1), matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF) (Shoemaker et al., 2021). While the CIRS diagnostic framework remains debated, the underlying biology—that chronic low-level antigen exposure can sustain inflammation in susceptible hosts—is consistent with established immunology.

A 2022 review in *Biological Psychiatry* examined the role of chronic inflammation in functional somatic syndromes, including fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome. The authors noted that these conditions share elevated inflammatory markers, altered hypothalamic-pituitary-adrenal axis function, and heightened central sensitization, suggesting a common neuroimmune substrate (Kraynak et al., 2022). Importantly, they found that psychosocial stress—particularly early life adversity and chronic unpredictability—primes the immune system toward a pro-inflammatory phenotype, a phenomenon termed "inflammatory priming" (Nusslock & Miller, 2021). This is not psychosomatic in the pejorative sense. It is a biological embedding of experience.

The nervous system's role in resolving inflammation is equally critical. Specialized pro-resolving mediators (SPMs)—lipid molecules such as resolvins, protectins, and maresins—are synthesized from omega-3 fatty acids and actively terminate inflammatory signaling (Serhan, 2023). Vagal tone, sleep, and circadian alignment all enhance SPM production. Disruption of these processes—chronic stress, sleep deprivation, circadian misalignment—impairs resolution and locks the system into a state of smoldering inflammation. The nervous system, in other words, does not just start inflammation. It decides when to stop.

The Nervous System Intelligence framework holds that the nervous system is a prediction engine, continuously generating models of the body and world, and revising those models in light of new evidence. Inflammation, in this view, is not an error. It is a prediction about threat and the allocation of metabolic resources toward defense.

When the nervous system predicts that the body is under attack—whether from pathogens, toxins, tissue damage, or chronic psychosocial threat—it orchestrates an inflammatory response. This prediction is not conscious. It is encoded in the firing patterns of vagal afferents, the release of cortisol and catecholamines, the activation of microglia, the permeability of the blood-brain barrier. If the threat resolves, the prediction updates, and pro-resolving pathways are engaged. If the threat persists—or if the nervous system continues to predict threat even after the original insult has passed—inflammation becomes chronic.

This is where the NIRVA Method becomes operationally relevant. The six movements—Notice, Interrupt, Identify, Regulate, Validate, Align—are not metaphors for self-care. They are a protocol for revising maladaptive predictions.

**Notice** is the recognition that something is off: fatigue that does not resolve with rest, pain without clear injury, mood that does not match circumstance. In the context of inflammation, noticing might include tracking patterns of symptom flare, environmental exposures, or the temporal relationship between stress and physical symptoms.

**Interrupt** is the deliberate disruption of automaticity. If the nervous system has learned to predict threat in response to certain cues—crowded spaces, certain foods, mold exposure, interpersonal conflict—interruption creates a window for revision. This might involve removing the exposure, but it also involves changing the context in which the nervous system interprets that exposure.

**Identify** is the process of naming the prediction. Not "I am broken," but "my nervous system is predicting threat." Not "inflammation is attacking me," but "my immune system is responding to a signal my nervous system believes is dangerous." This is not semantic. It is a shift from helplessness to agency.

**Regulate** is the most directly implicated movement in neuroimmune health. Vagal tone, heart rate variability, sleep quality, circadian alignment, and metabolic flexibility are all regulators of inflammatory tone. Practices that enhance parasympathetic activity—slow breathing, cold exposure, certain forms of movement, social connection—directly modulate cytokine production.

**Validate** is the acknowledgment that the nervous system's predictions, even when maladaptive, were formed for a reason. If chronic inflammation follows early life adversity, the nervous system is not overreacting. It is responding to a world it learned was dangerous. Validation does not mean resignation. It means understanding the logic of the system before attempting to change it.

**Align** is the integration of revised predictions into daily life. This is where behavior, environment, and biology converge. It might mean changing living conditions to reduce mold exposure, restructuring work to reduce chronic stress, or building routines that support circadian health. Alignment is not optimization. It is coherence between what the nervous system predicts and what the environment actually offers.

For clinicians, the neuroimmune perspective offers a framework for patients who do not fit neatly into diagnostic categories. The patient with unexplained fatigue, cognitive impairment, and elevated inflammatory markers is not a diagnostic failure. They are a person whose nervous system is maintaining an inflammatory posture in response to signals—environmental, metabolic, psychosocial—that have not been identified or addressed.

The first clinical task is measurement. Basic inflammatory markers—CRP, erythrocyte sedimentation rate (ESR)—are widely available but crude. More specific panels—cytokine profiles, complement markers, TGF-β1, MMP-9—are available through specialty labs and may be warranted in cases suggestive of CIRS or other chronic inflammatory syndromes. Visual contrast sensitivity testing, while unconventional, has been used as a functional marker of neurotoxin exposure. HLA-DR/DQ genotyping may identify genetic susceptibility to biotoxin-related illness, though its clinical utility remains debated.

The second task is environmental assessment. A careful history of water damage, mold exposure, tick-borne illness, and occupational or residential toxin exposure is essential. Many patients with CIRS report symptom onset or exacerbation following a move, renovation, or flooding event. Dismissing these narratives as coincidental or psychosomatic is a missed opportunity.

The third task is nervous system support. This is not ancillary. Vagal tone, sleep, circadian alignment, and metabolic health are not lifestyle factors—they are regulators of immune function. Interventions that enhance parasympathetic activity—breathwork, cold exposure, certain forms of manual therapy, even transcutaneous vagus nerve stimulation—have measurable anti-inflammatory effects. Sleep extension and circadian realignment reduce IL-6 and CRP. Omega-3 supplementation supports specialized pro-resolving mediator synthesis.

The fourth task is psychological. Chronic inflammation is often accompanied by shame, self-blame, and diagnostic gaslighting. Patients are told their symptoms are "all in their head," when in fact their symptoms are in their nervous system—which is to say, in their biology. Validating the reality of their experience, naming the neuroimmune mechanisms at play, and offering a coherent explanatory framework can itself be therapeutic.

Finally, clinicians must recognize the limits of current evidence. CIRS remains controversial. The diagnostic criteria are not universally accepted. The treatments—cholestyramine, antifungals, vasoactive intestinal peptide (VIP)—are not FDA-approved for this indication and lack large-scale randomized controlled trial support. But absence of evidence is not evidence of absence. Many patients improve with environmental remediation and targeted anti-inflammatory support. Dismissing them because the syndrome does not fit conventional nosology is a failure of clinical imagination.

For the individual navigating chronic inflammation, the work begins with noticing patterns. Keep a symptom log that tracks not just what you feel, but when, where, and in what context. Do symptoms worsen in certain buildings, after certain foods, during certain seasons, or following certain social interactions. The nervous system is a pattern detector. Give it data.

Interrupt the default. If you suspect environmental triggers—mold, dust, chemical exposure—test the hypothesis. Spend a week away from your home or workplace and observe what changes. If symptoms improve, the environment is part of the signal. If they do not, look elsewhere. This is not about paranoia. It is about empiricism.

Regulate your nervous system with the same seriousness you would regulate blood sugar or blood pressure. Prioritize sleep. Protect your circadian rhythm by getting morning light and dimming screens at night. Practice slow, diaphragmatic breathing for five minutes twice daily. Consider cold exposure—brief, tolerable, repeated—as a way to enhance vagal tone and reduce inflammatory signaling. These are not wellness trends. They are interventions with measurable effects on cytokine production.

Validate your experience. If you have been told your symptoms are not real, or that you are anxious, or that you need to relax, know this: chronic inflammation is measurable. Neuroimmune communication is established biology. Your nervous system is doing what it was designed to do—predict threat and allocate resources accordingly. The question is not whether your symptoms are real. The question is what your nervous system is responding to, and whether that response can be revised.

Align your environment with your biology. If testing or clinical assessment suggests biotoxin exposure, remediate it. If inflammatory markers are elevated, work with a clinician to identify sources—metabolic, infectious, environmental, psychosocial—and address them systematically. If chronic stress is a driver, restructure your life to reduce unpredictability and increase agency. This is not about perfection. It is about reducing the gap between what your nervous system predicts and what your environment actually contains.